Determination of galactose-1-phosphate uridyltransferase (Gal-1-PUT) activity by tandem mass spectrometry is now available at the Palmieri Metabolic Disease Laboratory.March 7, 2013
Clinical Lab Products quotes Avni Santani, PhD, Scientific Director, Molecular Genetics Laboratory, in a story about next-gen sequencing.February 13, 2013
The Cytogenomics Laboratory at CHOP utilizes a genome-wide SNP array to identify genomic alterations associated with a wide variety of disorders.December 20, 2012
CHOP now offers testing for procalcitonin (PCT) that has been approved by the FDA for use in conjunction with other laboratory findings and clinical assessments to assist in the risk assessment for progression to severe sepsis and septic shock.September 21, 2012
The Molecular Genetics Laboratory at the Children’s Hospital of Philadelphia announced the introduction of a diagnostic test for the Noonan spectrum of disorders using next generation sequencing technology.August 3, 2012
Ask for more information about our laboratory services.